Incidence of exudative age-related macular degeneration among elderly Americans.
about
Scanning laser entoptic perimetry for the detection of age-related macular degeneration.Resource use and costs associated with diabetic macular edema in elderly persons.Cigarette smoke-related hydroquinone dysregulates MCP-1, VEGF and PEDF expression in retinal pigment epithelium in vitro and in vivo.Cigarette smoke-related hydroquinone induces filamentous actin reorganization and heat shock protein 27 phosphorylation through p38 and extracellular signal-regulated kinase 1/2 in retinal pigment epithelium: implications for age-related macular degResource utilization and costs of age-related macular degeneration.Ocular biodistribution of bevasiranib following a single intravitreal injection to rabbit eyes.Nicotine increases the VEGF/PEDF ratio in retinal pigment epithelium: a possible mechanism for CNV in passive smokers with AMDRacial differences in age-related macular degeneration rates in the United States: a longitudinal analysis of a managed care networkInhibition of proliferation, migration and invasiveness of endothelial murine cells culture induced by resveratrol.Cost-effectiveness of autologous retinal pigment epithelium and choroid translocation in neovascular AMDImmune mechanisms in inflammatory and degenerative eye disease.Current progress of siRNA/shRNA therapeutics in clinical trials.Adverse events with intravitreal injection of vascular endothelial growth factor inhibitors: nested case-control study.Neuroprotective effects of nonfeminizing estrogens in retinal photoreceptor neuronsCannabinoid receptor 1 blockade protects human retinal pigment epithelial cells from oxidative injury.Effects of receipt of guideline-recommended care on onset of diabetic retinopathy and its progression.Longitudinal incidence of adverse outcomes of age-related macular degeneration.Handheld shape discrimination hyperacuity test on a mobile device for remote monitoring of visual function in maculopathy.Is age-related macular degeneration associated with stroke among elderly americans?Identification of persons with incident ocular diseases using health care claims databasesA hapten generated from an oxidation fragment of docosahexaenoic acid is sufficient to initiate age-related macular degenerationOxidative damage-induced inflammation initiates age-related macular degeneration.Infiltration of proinflammatory m1 macrophages into the outer retina precedes damage in a mouse model of age-related macular degeneration.Impact of HMG-CoA reductase inhibition on oxidant-induced injury in human retinal pigment epithelium cells.Presence and regulation of cannabinoid receptors in human retinal pigment epithelial cells.Light, lipids and photoreceptor survival: live or let die?Endoplasmic reticulum stress as a primary pathogenic mechanism leading to age-related macular degeneration.Targeting age-related macular degeneration with Alzheimer's disease based immunotherapies: anti-amyloid-beta antibody attenuates pathologies in an age-related macular degeneration mouse model.The Finnish national guideline for diagnosis, treatment and follow-up of patients with wet age-related macular degeneration.Age, sex, and type of medication predict the effect of anti-VEGF treatment on central retinal thickness in wet age-related macular degeneration.
P2860
Q31126206-3B1B4F71-2E6E-410F-B7F3-C20C484AECA5Q33390920-14C09E54-1639-4694-A492-6E9530B66B6AQ33840832-110CBCE7-9CE6-4AF8-A895-2DEB309C5F7AQ34086893-6301221F-E5CF-4FCA-BFBF-0838888AC7E1Q34328499-42527BDE-16E4-4AE9-B052-76E67BFC41E6Q34656454-3FFBF322-60F6-4E7C-9264-C34DA84DCCBBQ35027712-3EEBD902-6310-4A9D-BA33-D7169D275417Q35127011-6ABB1FF6-2EEE-4387-899A-F9AC5E7B0C85Q35631662-C5928676-D12F-4C59-988A-C12BC6AD16F1Q35923674-2534FA0C-DE65-4BE4-8725-E21DFEC0337FQ36040908-BDD1D09A-90A8-4295-9670-60741EE54502Q36071638-D3FD41D9-0D4F-46F0-A78D-A7AA3F3AC146Q36075546-BD7B4E53-C3A8-44CE-B1CC-17DE91431C43Q36223814-0A67D709-726E-49B8-B536-23DB51FDC46DQ36634698-99C63E68-6E1A-4159-89E2-BFF2BE1F0128Q36740561-CD61DDFB-D0FC-45B1-B19C-573E0F286FC9Q36753960-458631EE-6BBF-4A16-8B67-B479FBB64021Q37095340-A143CB70-62F3-4023-890F-B2E2D029FAB0Q37206264-BED73D76-9516-49E3-AF6E-F359059A9C19Q37333129-B6FFFC94-AA79-4815-AA68-D5A32613971CQ37351663-D2C42C1E-C73B-4009-A156-A7529D19BBDFQ37357471-56561E96-47CB-4403-84EE-FD904622C6A8Q39244149-66348F34-DD4A-4BCC-8014-25A5841F2286Q39547616-02E87BC9-1684-4B5E-81E8-51648A797CE7Q39834593-3A20CCE5-7D8A-40AE-848E-D88E85FC646FQ40703905-FBFCFA3A-0F0C-48F4-BE23-F245E215D74DQ42012939-8F60D5DE-C2DF-443B-B832-4DE5F58BA96FQ43151578-27EB8704-9B86-4CBE-8A1C-C2EE1620948DQ50903375-7C41D3BE-24AA-4942-BFA2-9859FEE40A73Q51736915-F83E5AA0-6F69-4C86-8D2C-947D9C918113
P2860
Incidence of exudative age-related macular degeneration among elderly Americans.
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Incidence of exudative age-related macular degeneration among elderly Americans.
@ast
Incidence of exudative age-related macular degeneration among elderly Americans.
@en
type
label
Incidence of exudative age-related macular degeneration among elderly Americans.
@ast
Incidence of exudative age-related macular degeneration among elderly Americans.
@en
prefLabel
Incidence of exudative age-related macular degeneration among elderly Americans.
@ast
Incidence of exudative age-related macular degeneration among elderly Americans.
@en
P2093
P1433
P1476
Incidence of exudative age-related macular degeneration among elderly Americans.
@en
P2093
Jonathan C Javitt
Maureen G Maguire
Richard J Willke
Stuart L Fine
Zhiyuan Zhou
P304
P356
10.1016/S0161-6420(03)00495-0
P577
2003-08-01T00:00:00Z